Insulet Corporation (1PODD)
MTA
Real-time Data
07:00 AM
Day's Range
129.3052 wk Range
110.00Overview - 1PODD - Insulet Corporation
Key Statistics
Valuation
Enterprise Value
7.92B
P/E (Trailing)
‪28.58‬
PEG Ratio
‪0.08‬
Price / Sales (TTM)
‪2.96‬
Price / Book
‪7.42‬
EV / EBITDA
‪15.04‬
Profitability
Gross Margin
‪70.17%‬
Profit Margin
‪12.29%‬
Operating Margin
‪16.17%‬
Return on Assets
‪9.71%‬
Return on Equity
‪26.01%‬
Ownership
Shares Outstanding
69.35M
Float
69.06M
Held by Insiders
‪0.32%‬
Held by Institutions
‪107.08%‬
Price stats
Beta
‪1.09‬
50-Day Avg
‪134.27‬
200-Day Avg
‪190.34‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1PODD - Insulet Corporation
Peers - 1PODD - Insulet Corporation
Peer Comparison
Compared with companies in Medical Devices listed on MTA.
Profile Summary - 1PODD - Insulet Corporation
About
Insulet Corporation is a medical device company that develops, manufactures, and sells innovative insulin delivery systems, primarily through its Omnipod product platform, for people with insulin-dependent diabetes worldwide. The Omnipod offers a tubeless, wearable Pod that provides up to three days of continuous…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
